Service area
M&S Labs services are open to residents of every U.S. state and Washington D.C. other than Alaska, California, Massachusetts, Mississippi, New Jersey, Rhode Island, or Vermont, where services are not offered at this time. If you live in one of those states, you will be unable to finish the intake process, and we will not collect any payment from you.
The assessment offered on the M&S Labs website does not establish a doctor-patient relationship between M&S Labs and the person who completes it. Antler Technologies Inc, a network of US-licensed doctors who follow rigorous medical protocols built around patient safety, has set exclusion criteria used to identify individuals who do not qualify for GLP-1s. As a result, a person's answers to the M&S Labs assessment determine whether they are screened out of eligibility for GLP-1 medication, and after checkout a Antler Technologies Inc clinician will meet with the person to decide whether they qualify for a prescription. The decision to prescribe compounded GLP-1s to patients remains with Antler Technologies Inc clinicians.
Every claim and benefit described on this website is based on self-reported data from GLP-1 customers on a treatment plan that includes compounded GLP-1 medications and consultations with medical professionals. Customers recorded their weight on their initial medical intake questionnaire and then every 3 to 4 weeks after that. Results from compounded medications available through the M&S Labs platform may vary and can be influenced by how closely an individual follows the program and their clinician's recommendations. Compounded GLP-1s are prepared by state-licensed compounding pharmacies. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, efficacy, or quality. The licensed provider's medical judgment, informed by a telehealth consultation and medical history, guides the decision to use compounded drugs.
We encourage anyone considering compounded medications to talk with their provider about the particular risks and benefits that using compounded medication may involve. M&S Labs does not make compounded medications, and the medication an individual receives may look different from what is shown on the website.
Results differ from person to person depending on starting weight, adherence to the program, and other factors, and they are not guaranteed. Prescribing medication is at the discretion of licensed medical providers, and a prescription may not be suitable for everyone. Weight management results rely on a healthy diet and regular exercise in addition to any prescribed treatment. Speak with a healthcare professional before taking medication or beginning any weight loss program.
The M&S Labs program includes medication. Wegovy® is FDA-approved for weight loss. Ozempic® is FDA-approved to treat type 2 diabetes but may be prescribed for weight loss. The trademarks, service marks, trade names (Wegovy®, Ozempic®), and products shown on this internet site are protected and are the property of their respective owners. Antler Technologies Inc, an affiliated network of medical professional corporations and associations, provides medical treatment. None of the data, photos, claims or other information on this site is tied to results drawn from clinical trials, studies or public information, and it always represents M&S Labs patient experience.
Some materials on this website, such as text, images, and other media, may be created or enhanced with artificial intelligence technologies. We make no representation or warranty about the accuracy, completeness, or reliability of that content. People who appear in advertisements may be actors or AI depicting doctors, and they are not licensed medical professionals.
The testimonials on this website come from M&S Labs patients. To protect patient privacy, the images that accompany those testimonials may use models or AI.
© 2026 M&S Labs. All rights reserved.
Medical services are provided by Antler Technologies Inc.